Navigation Links
Amicus Therapeutics Opens Research Facility in San Diego
Date:9/15/2008

CRANBURY, N.J. and SAN DIEGO, Sept. 15 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD), a biopharmaceutical company developing small molecule, orally-administered pharmacological chaperones for the treatment of human genetic diseases, today announced that the company has leased laboratory space for a focused, small scale research facility in San Diego. The facility will be used to support ongoing research into new applications of the company's platform technology.

"With proof of concept for pharmacological chaperones now established, research at the San Diego facility will support Amicus' efforts to expand our early stage pipeline," said David Lockhart, Ph.D., chief scientific officer for Amicus Therapeutics. "Locating the new laboratory in San Diego allows us to complement and expand our existing research capabilities in Cranbury by tapping into the significant resources and expertise of the San Diego science and biotechnology community."

"We believe pharmacological chaperones have significant potential to treat a broad range of genetic diseases," added John Crowley, president and CEO of Amicus. "The focus of our research efforts in San Diego will be to assess new chaperone applications in diseases with high unmet medical needs and larger patient populations particularly in the areas of neurodegenerative and metabolic disorders. This small scale facility will complement our core research and development activities in New Jersey."

The new laboratory space was included in Amicus' operating plan and budget for 2008 as part of increased investment in research beyond the lysosomal storage disorders. Amicus expects to begin occupying the space immediately.

About Amicus Therapeutics

Amicus Therape
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference
2. Amicus Therapeutics Announces Third Quarter 2007 Financial Results
3. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
4. Amicus Therapeutics to Present at the Lazard Capital Markets Fourth Annual Healthcare Conference
5. Amicus Therapeutics to Host R&D Day
6. Amicus Therapeutics Announces Positive Results From Phase 2 Clinical Trials of Amigal(TM) for Fabry Disease
7. Amicus Therapeutics Announces Fourth Quarter and Full Year 2007 Financial Results & Program Advancements
8. Amicus Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
9. Amicus Therapeutics to Present at the BIO CEO & Investor Conference 2008
10. Amicus Therapeutics Presents Positive Data from Phase 2 Clinical Trial of Plicera(TM) for Gaucher Disease
11. Amicus Therapeutics to Present at the Morgan Stanley Global Healthcare Unplugged Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The Oklahoma tornado left the state ... mayor of Moore, one of the heavily damaged towns, proposed ... from cnn.com. Reaching out to also be of help, My ... Shield to counter the looming mold problem. , The ... 2013, caused 24 deaths, My Cleaning Products shared. Ten of ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Quincy ... discovery and development of calcium-binding proteins to support ... safety assessment study of apoaequorin in ... journal published for the British Industrial Biological Research ... was to investigate potential adverse effects, if any, ...
(Date:5/23/2013)... Every day, their baby stopped breathing, his collapsed bronchus ... April and Bryan Gionfriddo watched helplessly, just praying that ... few doctors said he had a good chance of ... her now 20-month-old son, Kaiba. "At that point, we ... it and run with it." , They found hope ...
(Date:5/23/2013)... , May 23, 2013  BioScrip, Inc. (NASDAQ: ... present at the Jefferies 2013 Global Healthcare Conference to ... New York. Richard Smith ... Hai Tran , Chief Financial Officer, will present ... Daylight Time.   About BioScrip BioScrip, ...
Breaking Biology Technology:Mayor of Oklahoma-Tornado-Impaired Town Proposes Storm Shelter Bill, My Cleaning Products Offers Complimentary Molderizer and Safe Shield to Help Victim with Looming Mold 2Safety Assessment Study of Apoaequorin Published in Food and Chemical Toxicology 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 2Baby's life saved with groundbreaking 3-D printed device that restored his breathing 3
... China, Feb. 7 /Xinhua-PRNewswire-FirstCall/ -- Tianyin,Pharmaceutical, Inc., (OTC ... traditional Chinese medicine (TCM) based in Chengdu,China, today ... the Board of,Directors, will host a conference call ... results., The conference call will take place ...
... 7 Dilon Technologies, makers of,a gamma imaging system ... Moussa to the position of President and Chief Executive,Officer., ... the medical device industry,having held a number of senior ... a health care corporation he ran as,CEO for a ...
... 7 MedImmune today announced,that it has strengthened ... affairs with three key promotions and has also ... Kiener, D. Phil. has been appointed,to executive vice ... organization development, HR; and Eileen Valenta to vice ...
Cached Biology Technology:Tianyin Pharmaceutical, Inc. to Host 2008 Second Quarter Earnings Conference Call on Thursday, February 14, 2008 at 4:15 p.m. EST 2Newly Appointed Dilon Technologies President & CEO Robert G. Moussa Sees BSGI as ' ... Major Weapon in the Battle Against Cancer' 2MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 2MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 3MedImmune Strengthens Key Leadership Functions to Further Support Recently Expanded, Rapidly Advancing Product Portfolio 4
(Date:5/23/2013)... said to be the world,s most popular fruit, can ... research with purple GM varieties. , "Working with ... by the addition of a specific compound, allows us ... said Professor Cathie Martin from the John Innes Centre. ... with better flavour, health and shelf life characteristics because ...
(Date:5/23/2013)... By discovering the new mechanism by which estrogen suppresses ... revealed a potential new approach toward treating certain liver ... and colleagues believe they are changing long-held views in ... issue of the journal Science Signaling . , ... years has been that only receptors located in the ...
(Date:5/23/2013)... (May 23, 2013) A new report from the ... helping pupils engage in at least 60 minutes of ... , No more than half of American youth meet ... vigorous or moderate intensity physical activity daily, according to ... children are in school for nearly half of their ...
Breaking Biology News(10 mins):The world's favorite fruit only better-tasting and longer-lasting 2UCI study reveals new mechanism for estrogen suppression of liver lipid synthesis 2Schools should provide students with daily physical activity, IOM recommends 2
... at The University of Texas at Austin have devised a ... help people with Parkinson,s disease. The worms are able ... The researchers have received federal funding that could increase that ... is based on the difficulty that these "parkinsonian" C. ...
... play a far greater role in the fate of African elephants ... on these largest terrestrial animals, according to a new University of ... week. In some of the best-documented cases to date, the ... one of the last strongholds of forest elephants in the Democratic ...
... tundra are growing faster, suggesting that at least some forests ... new study. While forests elsewhere are thinning from wildfires, ... white spruce trees in the far north of Alaska have ... 1950, the study has found. The health of forests globally ...
Cached Biology News:Parkinsonian worms may hold the key to identifying drugs for Parkinson's disease 2Parkinsonian worms may hold the key to identifying drugs for Parkinson's disease 3More than 50 percent decline in elephants in eastern Congo due to human conflict: UBC research 2Trees on tundra's border are growing faster in a hotter climate 2Trees on tundra's border are growing faster in a hotter climate 3Trees on tundra's border are growing faster in a hotter climate 4
... recombinant protein that has been shown to help ... of cDNA by reverse transcription, in vitro RNA ... Safe Inhibitor tightly binds RNases in a 1:1 ... RNases such as RNase A, RNase B, RNase ...
... The BIOLASE Core Kit contains ... perform polymerase assays on a ... In addition to dNTPs, the ... our widely used BIOLASE DNA ...
Chicken Aortic Smooth Muscle Cells (CAOSMC) (>500,000 cells)...
... The National Collection of Pathogenic ... authenticated human pathogenic viruses in ... is able to supply the ... from them, to the scientific ...
Biology Products: